Vimarsana
Biggest News Aggregation in the World

Biostatistics Shared Resource News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biostatistics Shared Resource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biostatistics Shared Resource Today - Breaking & Trending Today

Combined therapy makes headway for liver cancer - Vimarsana News

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without

Combined therapy makes headway for liver cancer - Vimarsana News

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without

Antibiotics after breast cancer linked to poorer survival, Stanford Medicine-led study finds - Vimarsana News

Antibiotics after breast cancer linked to poorer survival, Stanford Medicine-led study finds

Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.

Antibiotics linked to higher triple-negative breast cancer death risk - Vimarsana News

Antibiotics linked to higher triple-negative breast cancer death risk

Triple-negative breast cancer patients who take antibiotics within three years of diagnosis have a higher death risk, researchers report.

Breast cancer patients using antibiotics more likely to experience recurrence or death - Vimarsana News

Breast cancer patients using antibiotics more likely to experience recurrence or death

Women with triple-negative breast cancer who received multiple antibiotic prescriptions within three years after their cancer diagnosis were more likely to experience disease recurrence and to die from their cancer than those who took fewer courses of the drugs, according to a study by researchers at Stanford Medicine.